Denne overlevelse var større end den mediane 6- 9 måneders overlevelse, der blev forventet af rådgivende kliniske investigatorer for en lignende patientpopulation.
This survival was greater than the six-to-nine month median survival anticipated by consultant clinical investigators for a similar patient population.